Caterina Serra Selected Research

syncytin

11/2014	HIV Tat acts on endogenous retroviruses of the W family and this occurs via Toll-like receptor 4: inference for neuroAIDS.
1/2012	Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.
10/2009	Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis.
5/2007	Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Serra Research Topics

Disease

8	Multiple Sclerosis 01/2017 - 12/2003
3	Neoplasms (Cancer) 08/2019 - 01/2018
2	Progressive Multifocal Leukoencephalopathy 01/2020 - 01/2017
2	Disease Progression 02/2014 - 01/2008
1	Relapsing-Remitting Multiple Sclerosis 01/2020
1	Polyps 11/2019
1	Human Influenza (Influenza) 11/2019
1	Neoplasm Metastasis (Metastasis) 08/2019
1	Colorectal Neoplasms (Colorectal Cancer) 08/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2019
1	Colic (Abdominal Cramps) 01/2019
1	Carcinogenesis 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Necrosis 11/2014
1	Epstein-Barr Virus Infections 01/2013
1	Infections 01/2013
1	Infectious Mononucleosis (Glandular Fever) 01/2013
1	Acute Disease 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2008
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2007
1	Demyelinating Diseases (Demyelinating Disease) 01/2007
1	Inflammation (Inflammations) 01/2007

Drug/Important Bio-Agent (IBA)

4	syncytinIBA 11/2014 - 05/2007
3	Natalizumab (Tysabri)FDA Link 01/2020 - 02/2014
3	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 10/2009
3	Messenger RNA (mRNA)IBA 11/2019 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 07/2019 - 01/2008
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2013
2	MicroRNAs (MicroRNA)IBA 08/2019 - 01/2019
2	env Gene ProductsIBA 10/2009 - 01/2007
2	CytokinesIBA 05/2007 - 12/2003
1	factor AIBA 01/2020
1	Tumor Viral Antigens (Large T Antigen)IBA 11/2019
1	Viral ProteinsIBA 11/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2019
1	VaccinesIBA 11/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	EndonucleasesIBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	RNA Splicing FactorsIBA 01/2018
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	EBV-encoded nuclear antigen 1IBA 01/2013
1	RNA (Ribonucleic Acid)IBA 10/2009
1	Interferon LambdaIBA 02/2008
1	InterferonsIBA 01/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2008
1	Interferon-betaIBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007
1	Glycoproteins (Glycoprotein)IBA 05/2007

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2008